221 participants
A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-20
- Start Date:
- 2025-04-21
- Completion:
- 2026-05-13
Conditions
- Atopic Hand and Foot Dermatitis
Interventions
- DRUG
No Results Yet